Document is current
Any future updates will be listed below
-
Authors
Bendová, Kateřina Dvořáková
Groll, Tanja
Neužilová, Barbora
Krasulová, Kristýna
Nový, Zbyněk
Reissig, Falco
Steiger, Katja
Boxberg, Melanie
Eppard, Elisabeth
Wuestemann, Jan
Hajdúch, Marián
Jesinghaus, Moritz
Šimeček, Jakub
Kreissl, Michael C.
Petřík, Miloš
Notni, Johannes https://orcid.org/0000-0002-3964-3391
-
Funding
Funding for this research was provided by:
Technische Universität München
- License Information
-
More Information
Article History
Received: 10 April 2025
Accepted: 4 June 2025
First Online: 20 June 2025
Declarations
:
: Procedures involving laboratory mice and their care were conducted in conformity with the regulations and guidelines of the Czech Animal Protection Act (no. 246/1992) and with approval of the Czech Ministry of Education, Youth, and Sports (MSMT-35035/2019–3) and the Institutional Animal Welfare Committee of the Faculty of Medicine and Dentistry of Palacký University in Olomouc.
: The authors affirm that the patients provided written informed consent prior to the investigations.
: The authors affirm that the patients provided written informed consent for publication of data and images.
: J.N. is an inventor of patent applications related to αvβ6-integrin binding peptide conjugates (patent holder: TU Munich). J.N. and J.Š. are CSO and CEO, respectively, and co-founders of TRIMT GmbH (Radeberg, Germany) who has licensed IP from TU Munich. All other authors report no conflict of interests.
